The Makkah Health Cluster has signed a cooperation agreement with Canadian company AIZTech, which specializes in AI-powered medical diagnostics, to deploy the iSelfie platform across its facilities, including King Abdullah Medical City and several major hospitals in Makkah.
The signing ceremony was attended by Jean-Philippe Linteau, ambassador of Canada to Saudi Arabia; Dr. Mubarak Al-Mulhem, director general of healthcare at the Ministry of Investment; and Dr. Hatim Al-Omari, CEO of the Makkah Health Cluster, which oversees more than 10 hospitals in the city. Also present were Dr. Adel Tash, CEO of King Abdullah Medical City, and Tarek Sultan, vice chairman of Agility. The agreement was signed by Al-Omari and Mohamed Sheta, CEO of AIZTech.
This marks the first agreement of its kind in the Middle East, allowing patients to benefit from instant health assessments using AI through a short facial video, with no additional hardware required. The iSelfie platform analyzes the video to extract key health metrics including blood pressure, heart rate, blood oxygen saturation, and respiratory rate. The platform will be integrated into the patient-facing screens within hospital facilities and will be used with the assistance of medical staff.
Al-Omari said: “We are proud to be the first in the Kingdom and the region to adopt this advanced technology, which reflects our ongoing commitment to harnessing the latest digital solutions to enhance diagnostic efficiency and accelerate patient care. This step marks a qualitative leap toward a more advanced and innovative healthcare system, aligned with the goals of Saudi Vision 2030.”
Tash added: “In line with the spirit of digital transformation and the ambitious Saudi Vision 2030, we are pleased to launch this innovative AI-powered technology in Makkah. This launch is backed by a pivotal study conducted across the Kingdom, where the technology showed promising results when compared with 1,021 cases diagnosed using traditional medical devices. We are committed to expanding access to these advanced tools to benefit the wider community in the region.”
Sheta said: “We are honored to collaborate with one of the Kingdom’s leading public healthcare institutions. This agreement is a clear indicator of the growing trust in AI-powered healthcare solutions and reinforces our belief that remote, non-invasive early diagnostics will be a core part of healthcare’s future.”
Ambassador Linteau said: “Digital health innovation is gaining momentum in Canada, and Saudi Arabia is a market that is open to early adoption of innovation in the health sector.” He also expressed hope that the platform will achieve remarkable success in the early detection of health conditions in patients.
The iSelfie platform has proven its effectiveness through clinical trials conducted in Saudi Arabia, the US, Canada, and Brazil, including a national study supported by the Saudi Food and Drug Authority. Results showed that the platform provides accurate readings comparable to traditional medical devices, with the added benefits of rapid assessment, accessibility, and cost efficiency.
This collaboration aligns with the goals of Saudi Vision 2030, which places innovation and digital transformation at the heart of healthcare development by improving the quality of life, promoting preventive care, and expanding access to modern medical services.
